• Filing Date: 2019-08-13
  • Form Type: 10-Q
  • Description: Quarterly report
v3.19.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Revenues:        
Research and development revenue $ 390,874 $ 161,286 $ 793,401 $ 345,616
Costs and expenses:        
Costs of research and development revenue 322,228 129,116 650,131 275,925
Research and development 818,240 601,199 1,510,610 1,178,083
Research and development - related party 336,310 340,849 725,783 733,398
General and administrative 1,870,678 921,542 3,298,745 2,214,539
Foreign currency exchange loss (gain), net 4,932 (15,198) 10,966 (10,358)
Total costs and expenses 3,352,388 1,977,508 6,196,235 4,391,587
Loss from operations (2,961,514) (1,816,222) (5,402,834) (4,045,971)
Interest income 265,722 219,585 532,684 406,042
Loss before income taxes (2,695,792) (1,596,637) (4,870,150) (3,639,929)
Provision for income taxes 0 0 900 0
Net loss $ (2,695,792) $ (1,596,637) $ (4,871,050) $ (3,639,929)
Basic and diluted net loss per common share (USD per share) $ (0.10) $ (0.06) $ (0.18) $ (0.13)
Basic and diluted weighted-average common shares outstanding (in shares) 26,828,754 28,060,811 26,771,439 28,109,756